Features of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 3, 2010, Pages 235-241

  Tang, Julian W ^a   Shetty, Nandini ^b   Lam, Tommy Tsan Yuk ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epidemiology; H1N1 2009; Influenza; Pandemic; Seasonality

Indexed keywords

ANTIVIRUS AGENT;

DISEASE SEVERITY; DRUG RESISTANCE; DRUG SENSITIVITY; FACE MASK; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INTENSIVE CARE; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC; PUBLIC HEALTH; REVIEW; RISK FACTOR; SCHOOL HEALTH SERVICE; SEASONAL VARIATION; SEROLOGY; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PRIMARY PREVENTION; PUBLIC HEALTH; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWINE; TREATMENT OUTCOME; VACCINATION;

EID: 77951034603     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283375727     Document Type: Review

References (64)

1. Centers for Disease Control and Prevention (CDC). H1N1 flu: International situation update; October 2009. http://www.cdc.gov/h1n1flu/updates/ international/ 100209.htm. [Accessed 12 November 2009].
2. World Health Organization (WHO). Influenza-like illness in the United States and Mexico. http://www.who.int/csr/don/2009-04-24/en/index.html. [Accessed 2 November 2009].
3. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324:1557-1561.
4. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
5. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
6. Brown IH. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 2000; 74:29-46.
7. Komadina N, Roque V, Thawatsupha P, et al. Genetic analysis of two influenza A (H1) swine viruses isolated from humans in Thailand and the Philippines. Virus Genes 2007; 35:161-165.
8. Lee CS, Kang BK, Kim HK, et al. Phylogenetic analysis of swine influenza viruses recently isolated in Korea. Virus Genes 2008; 37:168-176.
9. Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122-1125.
10. Pielak RM, Schnell JR, Chou JJ. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci U S A 2009; 106:7379-7384.
11. Ferraris O, Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol 2008; 41:13-19.
12. Itoh Y, Shinya K, KisoM, et al. In vitro and in vivo characterization of new swineorigin H1N1 influenza viruses. Nature 2009; 460:1021-1025.
13. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009; 325:484-487.
14. Yen HL, Lipatov AS, Ilyushina NA, et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol 2007; 81:6890-6898.
15. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006; 312:399.
16. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45:169-173.
17. Putting influenza A H1N1 in its place. Lancet Infect Dis 2009; 9:331.
18. Viboud C, Tam T, Fleming D, et al. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006; 24:6701-6707.
19. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361:674-679.
20. Lipsitch M, Riley S, Cauchemez S, et al. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009; 361:112-115.
21. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:536-541.
22. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
23. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-689.
24. World Health Organization (WHO). Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009; 84:237-244.
25. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-1887.
26. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-1879.
27. White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A(H1N1). JAMA 2009; 302:1905-1906.
28. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888-1895.
29. Webb SA, Pettila V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-1934.
30. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-1919 influenza pandemic. Emerg Infect Dis 2008; 14:1193-1199.
31. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970.
32. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071-1074.
33. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:749-752.
34. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009; 58:497-500.
35. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458.
36. Vaillant L, La Ruche G, Tarantola A, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14:1-6.
37. Centers for Disease Control and Prevention (CDC). Persons for whom annual vaccination is recommended. http://www.cdc.gov/flu/professionals/acip/persons. htm. [Accessed 2 November 2009].
38. World Health Organization (WHO). Vaccines for pandemic influenza A (H1N1). http://www.who.int/csr/disease/swineflu/frequently-asked-questions/ vaccine- preparedness/en/. [Accessed 2 November 2009].
39. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:969-972.
40. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:893-896.
41. World Health Organization (WHO). Guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. http:// www.who.int/csr/resources/publications/swineflu/h1n1-guidelines-pharma ceutical-mngt.pdf. [Accessed 2 November 2009].
42. ProMED-mail. Oseltamivir contamination, rivers - Japan. ProMED-mail 2009; 3 October: 20091003.3439. http://www.promedmail.org.
43. Singer AC, Howard BM, Johnson AC, et al. Meeting report: risk assessment of Tamiflu use under pandemic conditions. Environ Health Perspect 2008; 116:1563-1567.
44. Singer AC, Johnson AC, Anderson PD, et al. Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River. Environ Health Perspect 2008; 116:A285-A286.
45. Singer AC, Nunn MA, Gould EA, et al. Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 2007; 115: 102-106.
46. Centers for Disease Control and Prevention (CDC). Three reports of oseltamivir resistant novel influenza A (H1N1) viruses. http://www.cdc.gov/ h1n1flu/ HAN/070909.htm. [Accessed 2 November 2009].
47. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361:2204-2207.
48. Centers for Disease Control and Prevention (CDC). Emergency use authorization of peramivir IV. http://www.cdc.gov/h1n1flu/eua/peramivir.htm. [Accessed 2 November 2009].
49. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
50. Chen H, Wang Y, Liu W, et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009; 15:1849-1850.
51. Greenbaum JA, Kotturi MF, Kim Y, et al. Preexisting immunity against swineorigin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106:20365-20370.
52. Clark TW, Pareek M, Hoschler K, et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine - preliminary report. N Engl J Med 2009; 361:2424-2435.
53. Greenberg ME, Lai MH, Hartel GF, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009. doi: 10.1056/NEJMoa0907413 2009.
54. Centers for Disease Control and Prevention (CDC). Allocation and distribution Q&A. http://www.cdc.gov/H1N1flu/vaccination/statelocal/ centralized- distribution-qa.htm. [Accessed 2 November 2009].
55. Centers for Disease Control and Prevention (CDC). Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009; 84:185-189.
56. Cauchemez S, Ferguson NM, Wachtel C, et al. Closure of schools during an influenza pandemic. Lancet Infect Dis 2009; 9:473-481.
57. Centers for Disease Control and Prevention (CDC). Update on school (k-12) and child care programs: interim CDC guidance in response to human infections with the novel influenza A (H1N1) virus. http://www.cdc.gov/ H1N1flu/k12-dismissal.htm. [Accessed 12 November 2009].
58. Sypsa V, Hatzakis A. School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill 2009; 14:1-7.
59. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009; 339:b3675.
60. Srinivasan A, Perl TM. Respiratory protection against influenza. JAMA 2009; 302:1903-1904.
61. Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among healthcare workers: a randomized trial. JAMA 2009; 302:1865-1871.
62. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009; 6 (Suppl 6):S783-S790.
63. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151:437-446.
64. Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 2009; 7:30.